Study on urine metabolic profiling and pathogenesis of hyperlipidemia.

CONCLUSION: The non-targeted metabolomic method based on UPLC-Q-TOF/MS technology can effectively identify potential biomarkers in the urine of HLP patients and explore the possible pathogenesis. Our research will lay a foundation for finding new targets for the treatment of HLP and provide a basis for clinical research on the treatment of HLP. PMID: 31059703 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31059703?dopt=Abstract

Source: International Journal of Clinical Chemistry - May 2, 2019 Category: Chemistry Authors: Yang L, Li Z, Song Y, Liu Y, Zhao H, Liu Y, Zhang T, Yuan Y, Cai X, Wang S, Wang P, Gao S, Li L, Li Y, Yu C Tags: Clin Chim Acta Source Type: research